CCDR: Volume 46–2/3 - Feb/Mar 2020: Public Health Network - Summary of the NACI Statement on the Use of Bivalent Factor H Binding Protein Meningococcal Serogroup B (MenB-fHBP) Vaccine for the Prevention of Meningococcal B Disease
There are no views created for this resource yet.
Additional Information
Created | February 6, 2020 |
---|---|
Format |